| Title |
Relationship of Vancomycin Minimum Inhibitory Concentration to Mortality in Patients With Methicillin-Resistant Staphylococcus aureus Hospital-Acquired, Ventilator-Associated, or Health-care-Associated Pneumonia
|
|---|---|
| Published in |
CHEST, June 2010
|
| DOI | 10.1378/chest.09-2453 |
| Pubmed ID | |
| Authors |
Nadia Z. Haque, Lizbeth Cahuayme Zuniga, Paula Peyrani, Katherine Reyes, Lois Lamerato, Carol L. Moore, Shruti Patel, Marty Allen, Edward Peterson, Timothy Wiemken, Ennie Cano, Julie E. Mangino, Daniel H. Kett, Julio A. Ramirez, Marcus J. Zervos, the Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia Investigators |
| Abstract |
Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), and health-care-associated pneumonia (HCAP). These infections are associated with significant morbidity, mortality, and cost. The impact of vancomycin minimum inhibitory concentration (MIC) on mortality for patients with MRSA pneumonia has not been determined. |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 3 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| South Africa | 1 | 1% |
| United States | 1 | 1% |
| Portugal | 1 | 1% |
| Japan | 1 | 1% |
| United Kingdom | 1 | 1% |
| France | 1 | 1% |
| Unknown | 81 | 93% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 14 | 16% |
| Other | 12 | 14% |
| Professor | 11 | 13% |
| Student > Bachelor | 8 | 9% |
| Student > Ph. D. Student | 8 | 9% |
| Other | 15 | 17% |
| Unknown | 19 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 42 | 48% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 7% |
| Agricultural and Biological Sciences | 6 | 7% |
| Nursing and Health Professions | 4 | 5% |
| Psychology | 3 | 3% |
| Other | 4 | 5% |
| Unknown | 22 | 25% |